ProfileGDS4718 / 216887_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 38% 32% 91% 39% 37% 36% 37% 39% 38% 40% 41% 38% 35% 33% 35% 47% 42% 30% 34% 30% 38% 38% 37% 41% 43% 36% 43% 28% 39% 33% 31% 49% 38% 37% 34% 33% 31% 36% 36% 86% 39% 38% 35% 30% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.9020938
GSM549102patient 115, normal, homogenized [OPG study]4.6366932
GSM549104patient 119, normal, homogenized [OPG study]9.4304491
GSM549108patient 138, normal, homogenized [OPG study]4.9840239
GSM549119patient 077, normal, homogenized [OPG study]4.8773137
GSM549133patient 032, cancer, homogenized [OPG study]4.7689536
GSM549139patient 042, cancer, homogenized [OPG study]4.8123137
GSM549099patient 107, normal, homogenized [OPG study]4.9563839
GSM549109patient 139, normal, homogenized [OPG study]4.9359638
GSM549110patient 046, normal, homogenized [OPG study]4.999940
GSM549114patient 063, normal, homogenized [OPG study]5.0035741
GSM549122patient 082, normal, homogenized [OPG study]4.8816538
GSM549134patient 033, cancer, homogenized [OPG study]4.7674635
GSM549136patient 036, cancer, homogenized [OPG study]4.6019433
GSM549140patient 044, cancer, homogenized [OPG study]4.7282135
GSM549111patient 047, normal, homogenized [OPG study]5.3453847
GSM549113patient 057, normal, homogenized [OPG study]5.0354642
GSM549132patient 031, cancer, homogenized [OPG study]4.547630
GSM549137patient 038, cancer, homogenized [OPG study]4.7105334
GSM549142patient 047, cancer, homogenized [OPG study]4.6782130
GSM549100patient 110, normal, homogenized [OPG study]4.9057238
GSM549107patient 135, normal, homogenized [OPG study]4.8704538
GSM549115patient 068, normal, homogenized [OPG study]4.7993137
GSM549116patient 072, normal, homogenized [OPG study]5.0156341
GSM549120patient 078, normal, homogenized [OPG study]5.1177443
GSM549131patient 030, cancer, homogenized [OPG study]4.7299836
GSM549118patient 074, normal, homogenized [OPG study]5.1298343
GSM549129patient 027, cancer, homogenized [OPG study]4.4594128
GSM549123patient 088, normal, homogenized [OPG study]4.9059439
GSM549124patient 006, cancer, homogenized [OPG study]4.7108633
GSM549126patient 015, cancer, homogenized [OPG study]4.5822131
GSM549128patient 025, cancer, homogenized [OPG study]5.4501749
GSM549103patient 117, normal, homogenized [OPG study]4.9785338
GSM549117patient 073, normal, homogenized [OPG study]4.8058737
GSM549138patient 041, cancer, homogenized [OPG study]4.6774434
GSM549141patient 045, cancer, homogenized [OPG study]4.6192733
GSM549130patient 028, cancer, homogenized [OPG study]4.5987731
GSM549101patient 111, normal, homogenized [OPG study]4.8366536
GSM549105patient 128, normal, homogenized [OPG study]4.8449736
GSM549106patient 134, normal, homogenized [OPG study]8.723186
GSM549112patient 048, normal, homogenized [OPG study]4.9209139
GSM549125patient 011, cancer, homogenized [OPG study]4.9158938
GSM549127patient 024, cancer, homogenized [OPG study]4.7570935
GSM549135patient 035, cancer, homogenized [OPG study]4.4761930